ArticleCancer management and research2019

Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).

Alain Vergnenègre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.